With its Communication on EU missions adopted on 29 September 2021, the Commission officially launched the Cancer Mission full implementation phase. The first Horizon Europe work programme for 2021-22, published last 16 June, will be updated with a full research and innovation agenda by the end of the year. A budget of EUR 378.2 million for the period 2021-23 will support actions looking to better understand and treat cancer, improve the quality of life of patients and their families, and establish high level collaboration within the cancer community by supporting a network of Comprehensive Cancer Infrastructures.
Dr Anton Berns, EACS President, welcomed the long-awaited implementation plan for the EU Mission on Cancer and stressed the importance that the Mission will fund high quality innovative research to make a difference for patients and have a tangible societal impact. "For jump-starting this important initiative, it will be crucial that incentivizing funding vehicles are put in place that appeal to both institutions and individual investigators » he said. « The highly successful ERC/SynergyERC programme comes to mind as an example. The EACS has presented, on behalf of the cancer community, concrete recommendations as to how to implement the mission by supporting infrastructures on translational research, clinical and prevention trials, outcomes research, and specific priority research areas as well as health-economics in order to secure affordable cancer care in the future. The EACS is committed to working with all stakeholders to reach the ambitious mission goal ».